CLINICAL_TRIALS
trial_result
· 2020-08-06
Clinical Trial Update: Enzastaurin for Patients With Metastatic Colorectal Cancer [Phase 2]
Summary
Phase 2 trial of enzastaurin for metastatic colorectal cancer has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Colonic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2020-08-06